Pfizer Inc. beat EPS estimates 100% of the time across 19 reported quarters (19 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.68 | — | — | Miss |
| Q12026 FY2026 | $0.71 | $0.75 | +5.6% | Beat |
| 2026-02-03 | $0.57 | $0.66 | +16.4% | Beat |
| Q3 FY2025 | $0.63 | $0.87 | +37.4% | Beat |
| Q2 FY2025 | $0.58 | $0.78 | +34.5% | Beat |
| Q1 FY2025 | $0.67 | $0.92 | +38.1% | Beat |
| 2025-02-04 | $0.47 | $0.63 | +33.6% | Beat |
| Q3 FY2024 | $0.61 | $1.06 | +72.6% | Beat |
| Q2 FY2024 | $0.46 | $0.60 | +31.0% | Beat |
| Q1 FY2024 | $0.52 | $0.82 | +58.9% | Beat |
| 2024-01-30 | $-0.19 | $0.10 | +152.6% | Beat |
| Q3 FY2023 | $-0.32 | $-0.17 | +46.9% | Beat |
Back to PFE overview · PFE holders · PFE KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.